Stryker Corporation

NYSE:SYK

Medical - Devices

Healthcare
$318.15 +3.08%

+$9.29 today

Market cap
$121.12B
Beta
0.79
P/E (TTM)
35.6
EPS (TTM)
$8.72
Dividend yield
1.11%
52W Low $281.00High $404.87

Volume 3.25M

Average 2.49M

SYK Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Stryker CorporationNYSE: SYK

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin widens to 19.4%

Net margin was 19.4% in Q2 FY2026, up 4.7 pp from a year earlier. On a trailing-twelve-month basis it was 14.4%, up 2.2 pp year over year. Over 3 fiscal years it widened by 0.1 pp.

Context

  • Net margin widened in 1 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 20 analysts of 21.1% for the fiscal year ending Dec 2026, up from 12.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
19.4%+7.0 pp QoQ
Last fiscal yearDec 2025
12.9%-0.3 pp YoY
LTMJun 2026
14.4%+2.2 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.7 pp+6.4 pp+1.8 pp
1 year-0.3 pp+8.2 pp+8.5 pp
3 years+0.1 pp+9.4 pp+9.3 pp
5 years+10.5 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
12.9%
Year-over-year change
-0.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How SYK compares with its peers on the latest reported figures

  • SYK's LTM Jun 2026 net margin of 14.4% is the 2nd highest of the 11 companies compared; the peer median is 2.7%.
  • Its year-over-year change of +2.2 pp is the 6th highest of 11, against a peer median of +1.7 pp.
  • Over three fiscal years its change of +0.1 pp compares with a peer median of +3.2 pp.
SYK Competitors Peer median
Net Margin for SYK and competitors
Company Period LTM level YoY 3-year change
GMEDGlobus Medical, Inc.LTM Jun 202617.0% +3.4 pp-0.3 pp
SYKStryker CorporationLTM Jun 202614.4% +2.2 pp+0.1 pp
MDTMedtronic plcLTM Jul 202613.9% +0.3 pp+1.2 pp
SNNSmith & Nephew plcFY202510.1% +3.0 pp+5.9 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 20269.5% -1.0 pp+5.2 pp
CNMDCONMED CorporationLTM Mar 20264.0% -5.0 pp+11.1 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 20261.5% +11.3 pp+18.4 pp
OFIXOrthofix Medical Inc.LTM Mar 2026-7.3% +10.5 pp-6.9 pp
ATECAlphatec Holdings, Inc.LTM Mar 2026-15.9% +9.8 pp+24.4 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026-30.1% -28.4 pp-43.2 pp
ENOVEnovis CorporationLTM Apr 2026-49.9% -12.3 pp-51.8 pp
Peer median (excluding SYK) 2.7%+1.7 pp+3.2 pp

Competitors are the stored peer set for SYK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.11B18.45B20.5B22.6B25.12B
Cost of Revenue6.4B7.41B8B8.05B9.05B
Gross Profit10.71B11.04B12.49B14.55B16.07B
Gross Margin62.6%59.8%61.0%64.4%64.0%
Research & Development1.13B1.23B1.29B1.47B1.58B
Selling, General & Admin5.81B6.08B6.92B7.5B8.65B
Operating Expenses6.95B7.31B8.21B10.86B11.18B
Depreciation & Amortization990M998M1.03B1.05B1.19B
EBITDA3.61B4.02B5.06B6.01B6.31B
EBITDA Margin21.1%21.8%24.7%26.6%25.1%
Operating Income3.76B3.73B4.28B3.69B4.89B
Operating Margin22.0%20.2%20.9%16.3%19.5%
Interest Income68M94M75M139M121M
Interest Expense337M337M356M396M607M
Other Income / Expenses(1.48B)(1.05B)(608M)(197M)(375M)
Income Before Tax2.28B2.68B3.67B3.49B4.51B
Pre-Tax Margin13.3%14.5%17.9%15.5%18.0%
Income Tax Expense287M325M508M499M1.27B
Net Income1.99B2.36B3.17B2.99B3.25B
Net Margin11.7%12.8%15.4%13.2%12.9%
EPS (Basic)5.296.238.347.868.49
EPS (Diluted)5.226.178.257.768.40
Weighted Avg Shares377M378.2M379.6M381M382.2M
Weighted Avg Shares (Diluted)382.3M382.2M383.7M385.6M382.2M

Stryker Corporation

NYSE:SYK

Intrinsic Alpha fair value

Locked

Current Price

$318.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.